| Year |
Citation |
Score |
| 2023 |
Witkowska K, Paczkowska-Walendowska M, Plech T, Szymanowska D, Michniak-Kohn B, Cielecka-Piontek J. Chitosan-Based Hydrogels for Controlled Delivery of Asiaticoside-Rich Extracts with Wound Healing Potential. International Journal of Molecular Sciences. 24. PMID 38139059 DOI: 10.3390/ijms242417229 |
0.361 |
|
| 2023 |
Matharoo N, Mohd H, Michniak-Kohn B. Transferosomes as a transdermal drug delivery system: Dermal kinetics and recent developments. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. e1918. PMID 37527953 DOI: 10.1002/wnan.1918 |
0.348 |
|
| 2023 |
Virani A, Dholaria N, Matharoo N, Michniak-Kohn B. A Study of Microemulsion Systems for Transdermal Delivery of Risperidone Using Penetration Enhancers. Journal of Pharmaceutical Sciences. PMID 37429357 DOI: 10.1016/j.xphs.2023.07.007 |
0.344 |
|
| 2023 |
Kalvodová A, Dvořáková K, Petrová E, Michniak-Kohn BB, Zbytovská J. The Contest of Nanoparticles: Searching for the Most Effective Topical Delivery of Corticosteroids. Pharmaceutics. 15. PMID 36839836 DOI: 10.3390/pharmaceutics15020513 |
0.408 |
|
| 2023 |
Virani A, Puri V, Mohd H, Michniak-Kohn B. Effect of Penetration Enhancers on Transdermal Delivery of Oxcarbazepine, an Antiepileptic Drug Using Microemulsions. Pharmaceutics. 15. PMID 36678811 DOI: 10.3390/pharmaceutics15010183 |
0.353 |
|
| 2022 |
Puri V, Froelich A, Shah P, Pringle S, Chen K, Michniak-Kohn B. Quality by Design Guided Development of Polymeric Nanospheres of Terbinafine Hydrochloride for Topical Treatment of Onychomycosis Using a Nano-Gel Formulation. Pharmaceutics. 14. PMID 36297605 DOI: 10.3390/pharmaceutics14102170 |
0.344 |
|
| 2022 |
Ramzan M, Gourion-Arsiquaud S, Hussain A, Gulati JS, Zhang Q, Trehan S, Puri V, Michniak-Kohn B, Kaur IP. In vitro release, ex vivo penetration, and in vivo dermatokinetics of ketoconazole-loaded solid lipid nanoparticles for topical delivery. Drug Delivery and Translational Research. PMID 34993923 DOI: 10.1007/s13346-021-01058-6 |
0.394 |
|
| 2021 |
Chen K, Puri V, Michniak-Kohn B. Iontophoresis to Overcome the Challenge of Nail Permeation: Considerations and Optimizations for Successful Ungual Drug Delivery. The Aaps Journal. 23: 25. PMID 33439400 DOI: 10.1208/s12248-020-00552-y |
0.311 |
|
| 2020 |
Haq A, Kumar S, Mao Y, Berthiaume F, Michniak-Kohn B. Thymoquinone-Loaded Polymeric Films and Hydrogels for Bacterial Disinfection and Wound Healing. Biomedicines. 8. PMID 32998437 DOI: 10.3390/biomedicines8100386 |
0.322 |
|
| 2020 |
Zhang ZJ, Michniak-Kohn B. Flavosomes, novel deformable liposomes for the co-delivery of anti-inflammatory compounds to skin. International Journal of Pharmaceutics. 585: 119500. PMID 32512226 DOI: 10.1016/J.Ijpharm.2020.119500 |
0.486 |
|
| 2020 |
Zhang J, Froelich A, Michniak-Kohn B. Topical Delivery of Meloxicam using Liposome and Microemulsion Formulation Approaches. Pharmaceutics. 12. PMID 32245190 DOI: 10.3390/Pharmaceutics12030282 |
0.46 |
|
| 2020 |
Lin H, Lin L, Choi Y, Michniak-Kohn B. Development and in-vitro evaluation of co-loaded berberine chloride and evodiamine ethosomes for treatment of melanoma. International Journal of Pharmaceutics. 119278. PMID 32229284 DOI: 10.1016/J.Ijpharm.2020.119278 |
0.496 |
|
| 2020 |
Shah P, Goodyear B, Haq A, Puri V, Michniak-Kohn B. Evaluations of Quality by Design (QbD) Elements Impact for Developing Niosomes as a Promising Topical Drug Delivery Platform. Pharmaceutics. 12. PMID 32182792 DOI: 10.3390/Pharmaceutics12030246 |
0.367 |
|
| 2019 |
Haq A, Chandler M, Michniak-Kohn B. Solubility-physicochemical-thermodynamic theory of penetration enhancer mechanism of action. International Journal of Pharmaceutics. 575: 118920. PMID 31863880 DOI: 10.1016/J.Ijpharm.2019.118920 |
0.486 |
|
| 2019 |
Caritá AC, Santos BF, Shultz JD, Michniak-Kohn B, Chorilli M, Leonardi GR. Vitamin C: One compound, several uses. Advances for delivery, efficiency and stability. Nanomedicine : Nanotechnology, Biology, and Medicine. 102117. PMID 31676375 DOI: 10.1016/J.Nano.2019.102117 |
0.306 |
|
| 2019 |
Ameen D, Michniak-Kohn B. Development and In vitro evaluation of Pressure Sensitive Adhesive Patch for the Transdermal Delivery of Galantamine: Effect of Penetration Enhancers and Crystallization Inhibition. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. PMID 30981946 DOI: 10.1016/J.Ejpb.2019.04.008 |
0.457 |
|
| 2018 |
Haq A, Michniak-Kohn B. Effects of solvents and penetration enhancers on transdermal delivery of thymoquinone: permeability and skin deposition study. Drug Delivery. 25: 1943-1949. PMID 30463442 DOI: 10.1080/10717544.2018.1523256 |
0.553 |
|
| 2018 |
Ramezanli T, Michniak-Kohn BB. Development and characterization of a topical gel formulation of adapalene-TyroSpheres and its clinical efficacy assessment. Molecular Pharmaceutics. PMID 29996653 DOI: 10.1021/acs.molpharmaceut.8b00318 |
0.393 |
|
| 2018 |
Haq A, Goodyear B, Ameen D, Joshi V, Michniak-Kohn B. Strat-M® Synthetic Membrane: Permeability Comparison to Human Cadaver Skin. International Journal of Pharmaceutics. PMID 29890259 DOI: 10.1016/J.Ijpharm.2018.06.012 |
0.448 |
|
| 2018 |
Haq A, Dorrani M, Goodyear B, Joshi V, Michniak-Kohn B. Membrane Properties for Permeability Testing: Skin versus Synthetic Membranes. International Journal of Pharmaceutics. PMID 29366943 DOI: 10.1016/J.Ijpharm.2018.01.029 |
0.404 |
|
| 2017 |
Lin H, Michniak-Kohn B, Xia Z, Xu L, Kang Q, Chen C, Ma S, Wu Q. Transdermal delivery of compounds with different lipophilicity and molecular weight from W/O microemulsions analyzed by UPLC-Q-TOF/MS and LC-MS/MS. Current Drug Delivery. PMID 29268684 DOI: 10.2174/1567201815666171221125411 |
0.39 |
|
| 2017 |
Silva SAME, Michniak-Kohn B, Leonardi GR. An overview about oxidation in clinical practice of skin aging. Anais Brasileiros De Dermatologia. 92: 367-374. PMID 29186250 DOI: 10.1590/Abd1806-4841.20175481 |
0.469 |
|
| 2017 |
Zhang J, Michniak-Kohn BB. Investigation of Microemulsion and Microemulsion Gel Formulations for Dermal Delivery of Clotrimazole. International Journal of Pharmaceutics. PMID 29170117 DOI: 10.1016/j.ijpharm.2017.11.041 |
0.356 |
|
| 2017 |
Ameen D, Michniak-Kohn B. Transdermal delivery of dimethyl fumarate for Alzheimer's disease: Effect of penetration enhancers. International Journal of Pharmaceutics. PMID 28709939 DOI: 10.1016/J.Ijpharm.2017.07.031 |
0.478 |
|
| 2016 |
Ramezanli T, Kilfoyle BE, Zhang Z, Michniak-Kohn BB. Polymeric Nanospheres for Topical Delivery of Vitamin D3. International Journal of Pharmaceutics. PMID 27810351 DOI: 10.1016/J.Ijpharm.2016.10.072 |
0.782 |
|
| 2016 |
Ramezanli T, Zhang Z, Michniak-Kohn BB. Development and Characterization of Polymeric Nanoparticle-Based Formulation of Adapalene for Topical Acne Therapy. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 27565687 DOI: 10.1016/j.nano.2016.08.008 |
0.469 |
|
| 2016 |
Dorrani M, Garbuzenko OB, Minko T, Michniak-Kohn B. Development of edge-activated liposomes for siRNA delivery to human basal epidermis for melanoma therapy. Journal of Controlled Release : Official Journal of the Controlled Release Society. 228: 150-8. PMID 26965957 DOI: 10.1016/J.Jconrel.2016.03.010 |
0.471 |
|
| 2015 |
Tsai PC, Lee S, Michniak-Kohn B. In vitro methods for screening transdermal formulations. Therapeutic Delivery. PMID 26419344 DOI: 10.4155/Tde.15.58 |
0.371 |
|
| 2015 |
Bhat R, Patel H, Tsai PC, Sun XL, Daoud D, Lalancette RA, Michniak-Kohn B, Pietrangelo A. Effect of residue structure on the thermal and thermoresponsive properties of γ-substituted poly(N-acryloyl-2-pyrrolidones) Polymer Chemistry. 6: 5993-6000. DOI: 10.1039/C5Py00649J |
0.318 |
|
| 2015 |
Sun XL, Tsai PC, Bhat R, Bonder EM, Michniak-Kohn B, Pietrangelo A. Thermoresponsive block copolymer micelles with tunable pyrrolidone-based polymer cores: Structure/property correlations and application as drug carriers Journal of Materials Chemistry B. 3: 814-823. DOI: 10.1039/C4Tb01494D |
0.363 |
|
| 2014 |
Dorrani M, Kaul M, Parhi A, LaVoie EJ, Pilch DS, Michniak-Kohn B. TXA497 as a topical antibacterial agent: comparative antistaphylococcal, skin deposition, and skin permeation studies with mupirocin. International Journal of Pharmaceutics. 476: 199-204. PMID 25263100 DOI: 10.1016/J.Ijpharm.2014.09.033 |
0.487 |
|
| 2014 |
Terebetski JL, Michniak-Kohn B. Combining ibuprofen sodium with cellulosic polymers: a deep dive into mechanisms of prolonged supersaturation. International Journal of Pharmaceutics. 475: 536-46. PMID 25219860 DOI: 10.1016/J.Ijpharm.2014.09.015 |
0.76 |
|
| 2014 |
Terebetski JL, Cummings JJ, Fauty SE, Michniak-Kohn B. Combined use of crystalline sodium salt and polymeric precipitation inhibitors to improve pharmacokinetic profile of ibuprofen through supersaturation. Aaps Pharmscitech. 15: 1334-44. PMID 24920524 DOI: 10.1208/S12249-014-0163-2 |
0.764 |
|
| 2013 |
Silva SM, Sousa JJ, Marques EF, Pais AA, Michniak-Kohn BB. Structure activity relationships in alkylammonium C12-gemini surfactants used as dermal permeation enhancers. The Aaps Journal. 15: 1119-27. PMID 23959685 DOI: 10.1208/s12248-013-9518-y |
0.421 |
|
| 2013 |
Susarla R, Sievens-Figueroa L, Bhakay A, Shen Y, Jerez-Rozo JI, Engen W, Khusid B, Bilgili E, Romañach RJ, Morris KR, Michniak-Kohn B, Davé RN. Fast drying of biocompatible polymer films loaded with poorly water-soluble drug nano-particles via low temperature forced convection. International Journal of Pharmaceutics. 455: 93-103. PMID 23911341 DOI: 10.1016/J.Ijpharm.2013.07.051 |
0.308 |
|
| 2013 |
Ghosh I, Michniak-Kohn B. Influence of critical parameters of nanosuspension formulation on the permeability of a poorly soluble drug through the skin--a case study. Aaps Pharmscitech. 14: 1108-17. PMID 23824877 DOI: 10.1208/S12249-013-9995-4 |
0.495 |
|
| 2013 |
Zhang Z, Tsai PC, Ramezanli T, Michniak-Kohn BB. Polymeric nanoparticles-based topical delivery systems for the treatment of dermatological diseases. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. 5: 205-18. PMID 23386536 DOI: 10.1002/wnan.1211 |
0.412 |
|
| 2013 |
Bose S, Du Y, Takhistov P, Michniak-Kohn B. Formulation optimization and topical delivery of quercetin from solid lipid based nanosystems. International Journal of Pharmaceutics. 441: 56-66. PMID 23262430 DOI: 10.1016/J.Ijpharm.2012.12.013 |
0.721 |
|
| 2013 |
Bose S, Michniak-Kohn B. Preparation and characterization of lipid based nanosystems for topical delivery of quercetin. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 48: 442-52. PMID 23246734 DOI: 10.1016/J.Ejps.2012.12.005 |
0.699 |
|
| 2012 |
Zhang Z, Michniak-Kohn BB. Tissue engineered human skin equivalents. Pharmaceutics. 4: 26-41. PMID 24300178 DOI: 10.3390/pharmaceutics4010026 |
0.447 |
|
| 2012 |
Kaushik D, O'Fallon K, Clarkson PM, Dunne CP, Conca KR, Michniak-Kohn B. Comparison of quercetin pharmacokinetics following oral supplementation in humans. Journal of Food Science. 77: H231-8. PMID 23094941 DOI: 10.1111/J.1750-3841.2012.02934.X |
0.539 |
|
| 2012 |
O'Fallon KS, Kaushik D, Michniak-Kohn B, Dunne CP, Zambraski EJ, Clarkson PM. Effects of quercetin supplementation on markers of muscle damage and inflammation after eccentric exercise. International Journal of Sport Nutrition and Exercise Metabolism. 22: 430-7. PMID 22805422 DOI: 10.1123/Ijsnem.22.6.430 |
0.535 |
|
| 2012 |
Kilfoyle BE, Sheihet L, Zhang Z, Laohoo M, Kohn J, Michniak-Kohn BB. Development of paclitaxel-TyroSpheres for topical skin treatment. Journal of Controlled Release : Official Journal of the Controlled Release Society. 163: 18-24. PMID 22732474 DOI: 10.1016/J.Jconrel.2012.06.021 |
0.81 |
|
| 2012 |
Ghosh I, Michniak-Kohn B. Design and characterization of submicron formulation for a poorly soluble drug: the effect of Vitamin E TPGS and other solubilizers on skin permeability enhancement. International Journal of Pharmaceutics. 434: 90-8. PMID 22633930 DOI: 10.1016/J.Ijpharm.2012.05.031 |
0.444 |
|
| 2012 |
Elele E, Shen Y, Susarla R, Khusid B, Keyvan G, Michniak-Kohn B. Electrodeless electrohydrodynamic drop-on-demand encapsulation of drugs into porous polymer films for fabrication of personalized dosage units. Journal of Pharmaceutical Sciences. 101: 2523-33. PMID 22527973 DOI: 10.1002/Jps.23165 |
0.343 |
|
| 2012 |
Ghosh I, Michniak-Kohn B. A comparative study of vitamin E TPGS/HPMC supersaturated system and other solubilizer/polymer combinations to enhance the permeability of a poorly soluble drug through the skin. Drug Development and Industrial Pharmacy. 38: 1408-16. PMID 22296239 DOI: 10.3109/03639045.2011.653363 |
0.423 |
|
| 2012 |
Sievens-Figueroa L, Bhakay A, Jerez-Rozo JI, Pandya N, Romañach RJ, Michniak-Kohn B, Iqbal Z, Bilgili E, Davé RN. Preparation and characterization of hydroxypropyl methyl cellulose films containing stable BCS Class II drug nanoparticles for pharmaceutical applications. International Journal of Pharmaceutics. 423: 496-508. PMID 22178619 DOI: 10.1016/J.Ijpharm.2011.12.001 |
0.313 |
|
| 2012 |
Silva SM, Hu L, Sousa JJ, Pais AA, Michniak-Kohn BB. A combination of nonionic surfactants and iontophoresis to enhance the transdermal drug delivery of ondansetron HCl and diltiazem HCl. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 80: 663-73. PMID 22137964 DOI: 10.1016/J.Ejpb.2011.11.010 |
0.524 |
|
| 2012 |
Wei R, Simon L, Hu L, Michniak-Kohn B. Effects of iontophoresis and chemical enhancers on the transport of lidocaine and nicotine across the oral mucosa. Pharmaceutical Research. 29: 961-71. PMID 22134780 DOI: 10.1007/S11095-011-0636-X |
0.434 |
|
| 2011 |
Hu L, Silva SM, Damaj BB, Martin R, Michniak-Kohn BB. Transdermal and transbuccal drug delivery systems: enhancement using iontophoretic and chemical approaches. International Journal of Pharmaceutics. 421: 53-62. PMID 21963468 DOI: 10.1016/J.Ijpharm.2011.09.025 |
0.478 |
|
| 2011 |
Zhang J, Michniak-Kohn B. Investigation of microemulsion microstructures and their relationship to transdermal permeation of model drugs: ketoprofen, lidocaine, and caffeine. International Journal of Pharmaceutics. 421: 34-44. PMID 21959104 DOI: 10.1016/J.Ijpharm.2011.09.014 |
0.393 |
|
| 2011 |
Meng X, Yang D, Keyvan G, Michniak-Kohn B, Mitra S. Synthesis and immobilization of micro-scale drug particles in cellulosic films. Colloids and Surfaces. B, Biointerfaces. 86: 181-8. PMID 21524894 DOI: 10.1016/J.Colsurfb.2011.03.040 |
0.331 |
|
| 2011 |
Rai V, Tan HS, Michniak-Kohn B. Effect of surfactants and pH on naltrexone (NTX) permeation across buccal mucosa. International Journal of Pharmaceutics. 411: 92-7. PMID 21443939 DOI: 10.1016/J.Ijpharm.2011.03.046 |
0.534 |
|
| 2011 |
Pingali K, Mendez R, Lewis D, Michniak-Kohn B, Cuitino A, Muzzio F. Mixing order of glidant and lubricant--influence on powder and tablet properties. International Journal of Pharmaceutics. 409: 269-77. PMID 21356286 DOI: 10.1016/J.Ijpharm.2011.02.032 |
0.303 |
|
| 2011 |
Rai V, Dayan N, Michniak-Kohn B. A comparative evaluation of photo-toxic effect of fractionated melanin and chlorpromazine hydrochloride on human (dermal fibroblasts and epidermal keratinocytes) and mouse cell line/s (fibroblast Balb/c 3T3). Toxicology in Vitro : An International Journal Published in Association With Bibra. 25: 538-44. PMID 21134440 DOI: 10.1016/j.tiv.2010.11.017 |
0.51 |
|
| 2011 |
Hu L, Damaj BB, Martin R, Michniak-Kohn BB. Enhanced in vitro transbuccal drug delivery of ondansetron HCl. International Journal of Pharmaceutics. 404: 66-74. PMID 21056647 DOI: 10.1016/J.Ijpharm.2010.10.052 |
0.421 |
|
| 2011 |
Batheja P, Sheihet L, Kohn J, Singer AJ, Michniak-Kohn B. Topical drug delivery by a polymeric nanosphere gel: Formulation optimization and in vitro and in vivo skin distribution studies. Journal of Controlled Release : Official Journal of the Controlled Release Society. 149: 159-67. PMID 20950659 DOI: 10.1016/J.Jconrel.2010.10.005 |
0.814 |
|
| 2011 |
Pingali K, Mendez R, Lewis D, Michniak-Kohn B, Cuitiño A, Muzzio F. Evaluation of strain-induced hydrophobicity of pharmaceutical blends and its effect on drug release rate under multiple compression conditions. Drug Development and Industrial Pharmacy. 37: 428-35. PMID 20942612 DOI: 10.3109/03639045.2010.521160 |
0.325 |
|
| 2011 |
Murthy NS, Bedoui F, Kilfoyle BE, Iovine C, Michniak-Kohn B, Kohn J. Monitoring the viscoelastic properties of skin in liquid environments using quartz crystal microbalance. Journal of Pharmaceutical Sciences. 100: 530-5. PMID 20653052 DOI: 10.1002/Jps.22281 |
0.785 |
|
| 2011 |
Kilfoyle BE, Kaushik D, Terebetski JL, Bose S, Michniak-Kohn BB. The Use of Quercetin and Curcumin in Skin Care Consumer Products Formulating, Packaging, and Marketing of Natural Cosmetic Products. 259-286. DOI: 10.1002/9781118056806.ch14 |
0.707 |
|
| 2010 |
Perumal O, Michniak-Kohn B, Touitou E, Roberts MS. A special issue on skin nanotechnology. Journal of Biomedical Nanotechnology. 6: 405-7. PMID 21329038 DOI: 10.1166/Jbn.2010.1142 |
0.42 |
|
| 2010 |
Kaushik D, Michniak-Kohn B. Percutaneous penetration modifiers and formulation effects: thermal and spectral analyses. Aaps Pharmscitech. 11: 1068-83. PMID 20582492 DOI: 10.1208/S12249-010-9469-X |
0.64 |
|
| 2010 |
Ganio MS, Armstrong LE, Johnson EC, Klau JF, Ballard KD, Michniak-Kohn B, Kaushik D, Maresh CM. Effect of quercetin supplementation on maximal oxygen uptake in men and women. Journal of Sports Sciences. 28: 201-8. PMID 20054739 DOI: 10.1080/02640410903428558 |
0.539 |
|
| 2010 |
Kaushik D, Costache A, Michniak-Kohn B. Percutaneous penetration modifiers and formulation effects. International Journal of Pharmaceutics. 386: 42-51. PMID 19900521 DOI: 10.1016/J.Ijpharm.2009.10.052 |
0.606 |
|
| 2010 |
Rai V, Ghosh I, Bose S, Silva SMC, Chandra P, Michniak-Kohn B. A transdermal review on permeation of drug formulations, modifier compounds and delivery methods Journal of Drug Delivery Science and Technology. 20: 75-87. DOI: 10.1016/S1773-2247(10)50011-X |
0.666 |
|
| 2010 |
Falcone R, Michniak-Kohn B. Under the skin Pharmaceutical Manufacturing and Packing Sourcer. 26-30. |
0.441 |
|
| 2009 |
Batheja P, Song Y, Wertz P, Michniak-Kohn B. Effects of growth conditions on the barrier properties of a human skin equivalent. Pharmaceutical Research. 26: 1689-700. PMID 19415472 DOI: 10.1007/S11095-009-9879-1 |
0.795 |
|
| 2009 |
Sintov AC, Zhang PJ, Michniak-Kohn BB. Cutaneous biotransformation of N-(4-bromobenzoyl)-S,S-dimethyliminosulfurane and its product, 4-bromobenzamide, leading to percutaneous penetration enhancement of drugs: initial evidence using hydrocortisone. Journal of Controlled Release : Official Journal of the Controlled Release Society. 133: 44-51. PMID 18950667 DOI: 10.1016/j.jconrel.2008.09.084 |
0.378 |
|
| 2008 |
Kaushik D, Batheja P, Kilfoyle B, Rai V, Michniak-Kohn B. Percutaneous permeation modifiers: enhancement versus retardation. Expert Opinion On Drug Delivery. 5: 517-29. PMID 18491979 DOI: 10.1517/17425247.5.5.517 |
0.717 |
|
| 2005 |
Michniak-Kohn BB, Wertz PW, Al-Khalili M, Meidan VM. Skin: Physiology and Penetration Pathways Delivery System Handbook For Personal Care and Cosmetic Products. 77-100. DOI: 10.1016/B978-081551504-3.50008-0 |
0.393 |
|
| Show low-probability matches. |